SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023657
Filing Date
2016-08-09
Accepted
2016-08-09 16:06:08
Documents
49
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20160630.htm 10-Q 1474713
2 EX-10.19 cala-ex1019_75.htm EX-10.19 56010
3 EX-31.1 cala-ex311_9.htm EX-31.1 13922
4 EX-31.2 cala-ex312_7.htm EX-31.2 13885
5 EX-32.1 cala-ex321_6.htm EX-32.1 6703
6 EX-32.2 cala-ex322_8.htm EX-32.2 6934
7 GRAPHIC ge2sgpnuenx1000001.jpg GRAPHIC 2910
  Complete submission text file 0001564590-16-023657.txt   4608493

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cala-20160630.xml EX-101.INS 1059134
9 XBRL TAXONOMY EXTENSION SCHEMA cala-20160630.xsd EX-101.SCH 26406
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20160630_cal.xml EX-101.CAL 29618
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20160630_def.xml EX-101.DEF 53646
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20160630_lab.xml EX-101.LAB 192678
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20160630_pre.xml EX-101.PRE 143290
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 161817896
SIC: 2834 Pharmaceutical Preparations